TY  - CONF
AU  - Alerany, C.
AU  - Fernandez, R.
AU  - Landete, L.
AU  - Rodriguez, A.
AU  - Sandoval, S.
AU  - Valdivia, M.
AU  - Gil, A.
PY  - 2018
DO  - 10.1016/j.jval.2018.09.2064
SN  - 1098-3015
UR  - https://hdl.handle.net/10668/27568
T2  - Value in health
LA  - en
PB  - Elsevier science inc
TI  - DETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
TY  - conference output
VL  - 21
ER  -